shulz/E+ by way of Getty Photos
Exicure (NASDAQ:XCUR) signed a MOU with GPCR Therapeutics aimed on the acquisition of GPCR USA, a subsidiary of GPCR Therapeutics, and the know-how switch and collaborative analysis on GPCR Therapeutics’ ongoing drug growth pipelines.
By way of this acquisition, Exicure plans to safe
